Tag Archives: BIO Investor Forum

FierceBiotech Names 2014 Fierce 15

FierceBiotech

FierceBiotech released their much-anticipated 2014 Fierce 15 list today, their annual list of private biotech upstarts to watch. We’ll be hearing from three of them at next month’s BIO Investor Forum, October 7-8 in San Francisco: Adaptimmune and Sutro Biopharma will be making company presentations, and Editas Medicine CEO Katrine Bosley will participate as a panelist in one of our therapeutic workshops, Gene Therapy Ascending? Today’s Advancements Over Past Hurdles. Here’s the scoop on each, Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Investor Forum Company Snapshot: InvivoSciences

inivosciences

What is your company’s lead product or technology? InvivoSciences, Inc. (IVS) is a leading developer of proprietary human 3D cell/tissue culture models for highly-predictive, multi-parameter phenotypic assays both in pharmacology safety & discovery screening and in personalized and regenerative medicine.  IVS’s Functional 3D tissue models recapitulate the physiological properties of human cardiac, smooth and skeletal muscle and connective tissue.  Application of induced pluripotent technology allows to fabricate tissues in diseased states, e.g., hereditary cardiac diseases, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

The Eyes Have It According to Recent VC Funding Patterns

BIO Investor Forum

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which human body parts are experiencing the biggest rise in funding. The report was based on data from thousands of financings of startups from 1999 through the first half of 2014, provided by VentureSource, a database owned by Dow Jones & Company. And while many would assume the funding was largely pumped in to cardiovascular disease, they would be wrong. “The Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Promising vaccine companies set to take the stage at BIO Investor Forum

BIO Investor Forum

It is no secret that vaccines are a hot space in biotech right now, and the 13th Annual BIO Investor Forum will feature several companies working on promising vaccine R&D. The event, scheduled for October 7-8 in San Francisco, Calif., will feature 120 late-stage private and emerging public company presentations. Attendees at the BIO Investor Forum will hear from Immunovaccine, a clinical-stage vaccine development company focused on product candidates for cancer therapy, infectious disease and Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Buzz of BIO to recognize the most innovative companies at the 2014 BIO Investor Forum™

BIF-BuzzofBIO-116x76

Nominations are now open for the Buzz of BIO at the 2014 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Early Stage Entrepreneurs and Late Stage Leaders. Early-stage companies looking for their next financing round or late-stage private companies hoping to make the valuable Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,